![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 4, 2329-2332, January 26, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
B and Induction of
Apoptosis*
From the Department of Pharmaceutical Sciences, University
of Colorado Health Sciences Center, Denver, Colorado 80262
Glucocorticoids (GCs) function, in part, through
the ability of the glucocorticoid receptor (GR) to activate gene
expression and in part through the transrepression of AP-1 and NF-
B.
Here we characterize the effect of GR DNA binding domain (DBD)
mutations, previously analyzed for changes in the ability to activate
gene expression or transrepress AP-1. We have identified a GR mutant capable of distinguishing between transrepression of NF-
B and AP-1.
Using circular dichroism spectroscopy, we show that this mutation does
not appreciably alter GR DBD conformation, suggesting that functional
differences between the mutant and wild type protein are the
result of an alteration of a specific interaction surface. These data
suggest that transrepression of NF-
B and AP-1 occurs through
distinct protein-protein interactions and argue against the hypothesis
that transrepression occurs through competition for a single
coactivator protein. Introduction of these mutations into GC-resistant
CEM lymphoblastic T cells restored dexamethasone (DEX)-mediated
apoptosis as did wild type GR regardless of whether these mutants were
transrepression or activation defective. Thus, DEX-mediated apoptosis
in transformed T cells is more complex than originally appreciated.
Supported through grants from the Arthritis Foundation and the
American Diabetes Association. To whom correspondence should be
addressed. Tel.: 303-315-194; Fax: 303-315-0274; E-mail: robert. scheinman{at}uchsc.edu.
This article has been cited by other articles:
![]() |
E. Charmandari, T. Kino, T. Ichijo, and G. P. Chrousos Generalized Glucocorticoid Resistance: Clinical Aspects, Molecular Mechanisms, and Implications of a Rare Genetic Disorder J. Clin. Endocrinol. Metab., May 1, 2008; 93(5): 1563 - 1572. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Newton and N. S. Holden Separating Transrepression and Transactivation: A Distressing Divorce for the Glucocorticoid Receptor? Mol. Pharmacol., October 1, 2007; 72(4): 799 - 809. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Edwards, J. Haas, R. A. Panettieri Jr., M. Johnson, and S. L. Johnston Corticosteroids and beta2 Agonists Differentially Regulate Rhinovirus-induced Interleukin-6 via Distinct Cis-acting Elements J. Biol. Chem., May 25, 2007; 282(21): 15366 - 15375. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Liberman, D. Refojo, J. Druker, M. Toscano, T. Rein, F. Holsboer, and E. Arzt The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction FASEB J, April 1, 2007; 21(4): 1177 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Mishra, J. P. Mishra, and A. Kumar Activation of JNK-dependent Pathway Is Required for HIV Viral Protein R-induced Apoptosis in Human Monocytic Cells: INVOLVEMENT OF ANTIAPOPTOTIC BCL2 AND c-IAP1 GENES J. Biol. Chem., February 16, 2007; 282(7): 4288 - 4300. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sanchez-Vega, N. Krett, S. T. Rosen, and V. Gandhi Glucocorticoid receptor transcriptional isoforms and resistance in multiple myeloma cells Mol. Cancer Ther., December 1, 2006; 5(12): 3062 - 3070. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Charmandari, T. Kino, T. Ichijo, K. Zachman, A. Alatsatianos, and G. P. Chrousos Functional Characterization of the Natural Human Glucocorticoid Receptor (hGR) Mutants hGR{alpha}R477H and hGR{alpha}G679S Associated with Generalized Glucocorticoid Resistance J. Clin. Endocrinol. Metab., April 1, 2006; 91(4): 1535 - 1543. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. V. Sionov, O. Cohen, S. Kfir, Y. Zilberman, and E. Yefenof Role of mitochondrial glucocorticoid receptor in glucocorticoid-induced apoptosis J. Exp. Med., January 23, 2006; 203(1): 189 - 201. [Abstract] [Full Text] [PDF] |
||||
![]() |
L.-G. Bladh, J. Liden, K. Dahlman-Wright, M. Reimers, S. Nilsson, and S. Okret Identification of Endogenous Glucocorticoid Repressed Genes Differentially Regulated by a Glucocorticoid Receptor Mutant Able to Separate between Nuclear Factor-{kappa}B and Activator Protein-1 Repression Mol. Pharmacol., March 1, 2005; 67(3): 815 - 826. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. M. Necela and J. A. Cidlowski Mechanisms of Glucocorticoid Receptor Action in Noninflammatory and Inflammatory Cells Proceedings of the ATS, November 1, 2004; 1(3): 239 - 246. [Full Text] [PDF] |
||||
![]() |
B. M. Necela and J. A. Cidlowski A Single Amino Acid Change in the First Zinc Finger of the DNA Binding Domain of the Glucocorticoid Receptor Regulates Differential Promoter Selectivity J. Biol. Chem., September 17, 2004; 279(38): 39279 - 39288. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Ma, K. Gee, W. Lim, K. Chambers, J. B. Angel, M. Kozlowski, and A. Kumar Dexamethasone Inhibits IL-12p40 Production in Lipopolysaccharide-Stimulated Human Monocytic Cells by Down-Regulating the Activity of c-Jun N-Terminal Kinase, the Activation Protein-1, and NF-{kappa}B Transcription Factors J. Immunol., January 1, 2004; 172(1): 318 - 330. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. De Bosscher, W. Vanden Berghe, and G. Haegeman The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression Endocr. Rev., August 1, 2003; 24(4): 488 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Wang, M. H. Malone, H. He, K. S. McColl, and C. W. Distelhorst Microarray Analysis Uncovers the Induction of the Proapoptotic BH3-only Protein Bim in Multiple Models of Glucocorticoid-induced Apoptosis J. Biol. Chem., June 20, 2003; 278(26): 23861 - 23867. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. C. Cogswell, D. F. Kashatus, J. A. Keifer, D. C. Guttridge, J. Y. Reuther, C. Bristow, S. Roy, D. W. Nicholson, and A. S. Baldwin Jr. NF-kappa B and Ikappa Balpha Are Found in the Mitochondria. EVIDENCE FOR REGULATION OF MITOCHONDRIAL GENE EXPRESSION BY NF-kappa B J. Biol. Chem., January 24, 2003; 278(5): 2963 - 2968. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ko, G. R. Cardona, A. Henrion-Caude, and W. W. Chin Identification and Characterization of a Tissue-Specific Coactivator, GT198, That Interacts with the DNA-Binding Domains of Nuclear Receptors Mol. Cell. Biol., January 1, 2002; 22(1): 357 - 369. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |